DrugPatentWatch Database Preview
Benztropine mesylate - Generic Drug Details
What are the generic drug sources for benztropine mesylate and what is the scope of patent protection?
Benztropine mesylate
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Navinta Llc, Oak Pharms Akorn, Aspen Global Inc, Chartwell Rx, Epic Pharma Llc, Invagen Pharms, Lannett Co Inc, Leading Pharma Llc, Oxford Pharms, Pliva, Quantum Pharmics, Upsher Smith Labs, Usl Pharma, Vintage, and Merck, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for benztropine mesylate. Twenty-two suppliers are listed for this compound.
Summary for benztropine mesylate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 18 |
| NDAs: | 28 |
| Drug Master File Entries: | 7 |
| Suppliers / Packagers: | 22 |
| Bulk Api Vendors: | 89 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,619 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for benztropine mesylate |
| Drug Sales Revenues: | Drug sales revenues for benztropine mesylate |
| DailyMed Link: | benztropine mesylate at DailyMed |
Recent Clinical Trials for benztropine mesylate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Boehringer Ingelheim | Phase 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
Pharmacology for benztropine mesylate
| Drug Class | Anticholinergic Antihistamine |
| Mechanism of Action | Cholinergic Antagonists Histamine Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for benztropine mesylate
Synonyms for benztropine mesylate
| (1R,3r,5S)-3-(benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate |
| (1r,5r)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate(1:1) |
| (1R,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid |
| (1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid |
| (1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid |
| 1-alpha-H,5-alpha-H-Tropane, 3-alpha-(diphenylmethoxy)-, methanesulfonate |
| 1.alpha.H, 3.alpha.-(diphenylmethoxy)-, methanesulfonate |
| 132-17-2 |
| 132B172 |
| 1alphaH,5alphaH-Tropane, 3alpha-(diphenylmethoxy)-, methanesulfonate |
| 1alphaH,5alphaH-Tropane, 3alpha-(diphenylmethoxy)-, methanesulfonate (8CI) |
| 3-(Benzhydryloxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate |
| 3-(diphenylmethoxy)-8-azabicyclo(3.2.1)octanendo-8-azabicyclo(3.2.1)octanmethanesulfonate |
| 3-(Diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane methane sulfonate |
| 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane methanesulfonate(1:1) |
| 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane, methanesulfonic acid |
| 3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid |
| 3-alpha-(Diphenylmethoxy)-1-alpha-H, 5-alpha-H-tropane methanesulfonate |
| 3-alpha-(diphenylmethoxy)-1-alpha-h,5-alpha-h-tropanemethanesulfonate |
| 3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid |
| 3-Diphenyl methoxytropane methanesulfonate |
| 3-Diphenylmethoxytropane mesylate |
| 3-Diphenylmethoxytropane methanesulfonate |
| 3a-(Diphenylmethoxy)-1a H,5a H-tropane methanesulfonate |
| 3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane methanesulfonate |
| 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-, methanesulfonate |
| 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-, methanesulfonate (9CI) |
| 8-Azabicyclo[3.2.1]octane, endo-, methanesulfonate |
| AB0021001 |
| AC1L1RAS |
| AC1L604T |
| AC1MMXWK |
| AC1Q4GST |
| AC1Q6WCX |
| ACN-051261 |
| AK122005 |
| AKOS008105137 |
| AKOS025214111 |
| AKOS026750089 |
| AN-11729 |
| AOB5795 |
| API0001645 |
| AS-17846 |
| AX8001513 |
| B 8262 |
| Benzatropine mesilate |
| benzatropine mesylate |
| Benzatropine methanesulfonate |
| benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether methanesulfonate |
| Benzophenone-3,3'-4,4'-tetracarboxylic dianhydrie |
| Benzotropine mesylate |
| Benzotropine methanesulfonate |
| Benzotropinemesylate |
| Benztropine (mesylate) |
| Benztropine mesilate |
| Benztropine mesilate (JAN) |
| Benztropine mesylate (USP) |
| Benztropine mesylate [USP] |
| Benztropine mesylate salt |
| Benztropine mesylate, >=98% (HPLC) |
| Benztropine mesylate, United States Pharmacopeia (USP) Reference Standard |
| Benztropine methanesulfonate |
| Benztropine methanesulfonate salt |
| Benztropine methylsulfonate |
| benztropinemesylate |
| C21H25NO.CH4O3S |
| CAS-132-17-2 |
| CCG-221176 |
| CCG-221498 |
| CCG-37380 |
| CHEBI:3049 |
| CHEMBL1200383 |
| CHEMBL1257125 |
| CHEMBL1442985 |
| Cobrentin methanesulfonate |
| Cogentin |
| Cogentin (TN) |
| Cogentin mesylate |
| Cogentin methanesulfonate |
| CPD000394012 |
| CS-2733 |
| CTK4B7776 |
| CTK7B4522 |
| D00778 |
| DSSTox_CID_25096 |
| DSSTox_GSID_45096 |
| DSSTox_RID_80668 |
| DTXSID0045096 |
| EBD49028 |
| EINECS 205-048-8 |
| EN300-51031 |
| endo-3-(Diphenylmethoxy)-8-methyl-8-azoniabicyclo(3.2.1)octane methanesulphonate |
| EU-0100194 |
| HMS2747A15 |
| HMS3259P11 |
| HMS3260H09 |
| HMS3652K07 |
| HMS3715L13 |
| HY-B0520A |
| I01-0267 |
| KB-47738 |
| KS-00000XL0 |
| Lopac-B-8262 |
| LP00194 |
| LS-157781 |
| MCULE-4736181346 |
| MK 02 |
| MLS000737056 |
| MolPort-003-844-725 |
| MolPort-023-278-114 |
| MolPort-042-652-432 |
| N-methylbenztropine |
| NC00646 |
| NCGC00013495 |
| NCGC00013495-01 |
| NCGC00013495-02 |
| NCGC00016118-01 |
| NCGC00016118-02 |
| NCGC00093670-01 |
| NCGC00096609-01 |
| NCGC00260879-01 |
| NCI42199 |
| NSC 169913 |
| NSC-169913 |
| NSC-42199 |
| NSC169913 |
| NSC42199 |
| Opera_ID_1229 |
| Q-200693 |
| s3163 |
| SAM002548938 |
| SB19689 |
| SC-20236 |
| SCHEMBL1648656 |
| SCHEMBL41808 |
| SCHEMBL41809 |
| SMR000394012 |
| SR-01000075303 |
| SR-01000075303-1 |
| SR-01000075303-5 |
| ST24041528 |
| ST50997629 |
| SW219521-1 |
| Tox21_110028 |
| Tox21_500194 |
| Tropine benzohydryl ether methanesulfonate |
| UNII-WMJ8TL7510 |
| V2115 |
| WLN: T56 A ANTJ A1 GOYR & R & OSW1 |
| WMJ8TL7510 |
US Patents and Regulatory Information for benztropine mesylate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vintage | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 040715-002 | Aug 27, 2007 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Oxford Pharms | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 040706-001 | Feb 14, 2008 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Aspen Global Inc | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 204713-003 | Apr 14, 2015 | AA | RX | No | Yes | Start Trial | Start Trial | Start Trial | |||
| Usl Pharma | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 089211-001 | Jun 14, 1988 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lannett Co Inc | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 088895-001 | Apr 11, 1985 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
